Kathrin Schumann

 

Position: Post-doctoral Fellow

emailkathrin.schumann [at] UCSF.edu

I grew up and studied Biochemistry in Germany. During my diploma and PhD thesis in Michael Sixt’s lab at the Max Planck Institute of Biochemistry near Munich I analyzed how the presenting mode of chemokines influences dendritic cell migration. After my PhD, I decided to gain experience in translational aspects of research and drug development. I joined the Novartis Postdoc Program in Basel, Switzerland, working within the autoimmune disease area. Beginning of March 2014 I am back in academia as a joint postdoc in the labs of Alex Marson and Jeffrey Bluestone. I am looking forward to learn more about regulatory circuits in T cells and to live in San Francisco…


CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Rupp LJ, Schumann K, Roybal KT, Gate RE, Ye CJ, Lim WA, Marson A. Scientific Reports. (2017)

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B, Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A, Krogan NJ, Marson A, Sabatini DM, Lander ES, Hacohen N, Walker BD. Nature Genetics. (2017).

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human Cells.
Hulquist J*, Schumann K*, Woo JM, Manganaro L, McGregor MJ, Doudna J, Simon V, Krogan NJ, Marson A. Cell Reports. (2016).

Generation of Knock-in Primary Human T Cells Using Cas9 Ribonucleoproteins.
Schumamn K*, Lin S*, Boyer E, Simeonov DR, Subramaniam M, Gate RE, Haliburton GE, Ye CJ, Bluestone JA, Doudna JA, Marson A. PNAS. (2015).